{"id":44094,"date":"2025-10-22T19:52:53","date_gmt":"2025-10-22T11:52:53","guid":{"rendered":"https:\/\/flcube.com\/?p=44094"},"modified":"2025-10-22T19:52:53","modified_gmt":"2025-10-22T11:52:53","slug":"indetek-laboratory-secures-nmpa-approval-for-idt%e2%80%91001-gel-a-novel-film%e2%80%91forming-therapy-for-sstis","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=44094","title":{"rendered":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs"},"content":{"rendered":"\n<p><strong>Indetek Laboratory<\/strong> announced that the <strong>National Medical Products Administration (NMPA)<\/strong> has formally accepted the <strong>New Drug Application (NDA)<\/strong> for its first product, <strong>IDT\u2011001 Gel<\/strong>. The gel is indicated for the treatment of <strong>Skin and Soft Tissue Infections (SSTIs)<\/strong> in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-highlights\"><strong>Key Highlights<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Milestone<\/strong> \u2013 First NDA acceptance by the NMPA for an Indetek product.<\/li>\n\n\n\n<li><strong>Broad Indication<\/strong> \u2013 Covers SSTIs from infants (\u22651\u202fyr) through adults, including renal\u2011impaired patients.<\/li>\n\n\n\n<li><strong>Innovative Delivery<\/strong> \u2013 Film\u2011forming, sustained\u2011release mechanism that creates a bio\u2011adhesive protective layer on the skin.<\/li>\n\n\n\n<li><strong>Clinical Advantage<\/strong> \u2013 Provides longer drug retention and a more sustained therapeutic effect versus conventional ointments or creams.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-idt-001-gel\"><strong>About IDT\u2011001 Gel<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mechanism of Action<\/strong> \u2013 Formed film releases active ingredient continuously at the infection site, maintaining effective concentrations.<\/li>\n\n\n\n<li><strong>Formulation Technology<\/strong> \u2013 Combines high\u2011viscosity polymer matrix with rapid\u2011adhesion properties, ensuring a stable barrier against microbial ingress.<\/li>\n\n\n\n<li><strong>Safety Profile<\/strong> \u2013 Pre\u2011clinical data show minimal systemic absorption and negligible local irritation.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-implications-for-healthcare\"><strong>Implications for Healthcare<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Improved Patient Compliance<\/strong> \u2013 Once\u2011daily application with sustained release reduces dosing frequency.<\/li>\n\n\n\n<li><strong>Expanded Therapeutic Reach<\/strong> \u2013 Effective in renal\u2011impaired patients where conventional antibiotics may pose dosing challenges.<\/li>\n\n\n\n<li><strong>Market Position<\/strong> \u2013 Positions Indetek as a first\u2011mover in the Chinese SSTI market with a differentiated product platform.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\"><strong>Forward\u2011Looking Statements<\/strong><\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New&#8230;<\/p>\n","protected":false},"author":1,"featured_media":44098,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[4407,38],"class_list":["post-44094","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","tag-indetek-laboratory","tag-market-approval-filings"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for its first product, IDT\u2011001 Gel. The gel is indicated for the treatment of Skin and Soft Tissue Infections (SSTIs) in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=44094\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs\" \/>\n<meta property=\"og:description\" content=\"Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for its first product, IDT\u2011001 Gel. The gel is indicated for the treatment of Skin and Soft Tissue Infections (SSTIs) in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=44094\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-22T11:52:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs\",\"datePublished\":\"2025-10-22T11:52:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094\"},\"wordCount\":253,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2203.webp\",\"keywords\":[\"Indetek Laboratory\",\"Market approval filings\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44094#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=44094\",\"name\":\"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2203.webp\",\"datePublished\":\"2025-10-22T11:52:53+00:00\",\"description\":\"Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for its first product, IDT\u2011001 Gel. The gel is indicated for the treatment of Skin and Soft Tissue Infections (SSTIs) in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44094\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2203.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2203.webp\",\"width\":1080,\"height\":608,\"caption\":\"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44094#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs - Insight, China&#039;s Pharmaceutical Industry","description":"Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for its first product, IDT\u2011001 Gel. The gel is indicated for the treatment of Skin and Soft Tissue Infections (SSTIs) in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=44094","og_locale":"en_US","og_type":"article","og_title":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs","og_description":"Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for its first product, IDT\u2011001 Gel. The gel is indicated for the treatment of Skin and Soft Tissue Infections (SSTIs) in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.","og_url":"https:\/\/flcube.com\/?p=44094","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-22T11:52:53+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=44094#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=44094"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs","datePublished":"2025-10-22T11:52:53+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=44094"},"wordCount":253,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=44094#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp","keywords":["Indetek Laboratory","Market approval filings"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=44094#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=44094","url":"https:\/\/flcube.com\/?p=44094","name":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=44094#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=44094#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp","datePublished":"2025-10-22T11:52:53+00:00","description":"Indetek Laboratory announced that the National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for its first product, IDT\u2011001 Gel. The gel is indicated for the treatment of Skin and Soft Tissue Infections (SSTIs) in patients aged one year and older, including infants, adults, those with renal impairment, and large\u2011area infections.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=44094#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=44094"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=44094#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp","width":1080,"height":608,"caption":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=44094#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Indetek Laboratory Secures NMPA Approval for IDT\u2011001 Gel, a Novel Film\u2011Forming Therapy for SSTIs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2203.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=44094"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44094\/revisions"}],"predecessor-version":[{"id":44099,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44094\/revisions\/44099"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/44098"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=44094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=44094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=44094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}